SEC Form 4 · accession 0000899243-18-015955
SOLENO THERAPEUTICS INC · SLNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ernest Mario
Director · 10% Owner
Period of report
Jun 7, 2018
Accepted (ET)
Jun 11, 2018 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001484565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 7, 2018 | A | 4,611 | $2.0025 | A | 451,435 | D | |
| Common Stock | Jun 8, 2018 | A | 14,803 | $2.044 | A | 466,238 | D |
Table II — derivative securities
No Table II lines on this filing.